Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 5348 | 1567 | 36.7 | 80% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1220 | 8650 | TRIMETAZIDINE//DIABETIC CARDIOMYOPATHY//PERHEXILINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SILENT MYOCARDIAL ISCHAEMIA | Author keyword | 9 | 45% | 1% | 15 |
| 2 | SILENT CORONARY ARTERY DISEASE | Author keyword | 8 | 100% | 0% | 5 |
| 3 | SILENT MYOCARDIAL ISCHEMIA | Author keyword | 5 | 19% | 2% | 24 |
| 4 | INTENS CARDIAC CORONARY UNIT | Address | 5 | 38% | 1% | 10 |
| 5 | ADMISSION GLUCOSE | Author keyword | 3 | 57% | 0% | 4 |
| 6 | HEART VESSEL | Address | 3 | 19% | 1% | 14 |
| 7 | SILENT ISCHAEMIA | Author keyword | 3 | 33% | 0% | 7 |
| 8 | KYUSYU CARDIOVASC | Address | 2 | 67% | 0% | 2 |
| 9 | SANA HOSP GER HEIM | Address | 2 | 67% | 0% | 2 |
| 10 | GLUCOSE ABNORMALITIES | Author keyword | 2 | 40% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EURO HEART | 71 | 75% | 3% | 51 |
| 2 | NONDIABETIC PATIENTS | 33 | 22% | 9% | 137 |
| 3 | ADMISSION GLUCOSE | 30 | 69% | 2% | 25 |
| 4 | STRESS HYPERGLYCEMIA | 23 | 21% | 6% | 95 |
| 5 | DIAD | 13 | 50% | 1% | 19 |
| 6 | INSULIN GLUCOSE INFUSION | 12 | 47% | 1% | 18 |
| 7 | ADMISSION PLASMA GLUCOSE | 11 | 54% | 1% | 14 |
| 8 | ABNORMAL GLUCOSE REGULATION | 10 | 57% | 1% | 12 |
| 9 | DIGAMI | 8 | 60% | 1% | 9 |
| 10 | THROMBOLYTIC ERA | 7 | 33% | 1% | 18 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Acute Hyperglycemia in Patients With Acute Myocardial Infarction | 2012 | 22 | 48 | 50% |
| Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary - The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) | 2007 | 865 | 598 | 10% |
| Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis | 2011 | 18 | 50 | 46% |
| Is type 2 diabetes really a coronary heart disease risk equivalent? | 2013 | 7 | 37 | 70% |
| Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options | 2010 | 19 | 70 | 44% |
| Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target? | 2009 | 12 | 55 | 84% |
| Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction | 2008 | 19 | 46 | 72% |
| Hyperglycemia in Nondiabetic Patients Presenting With Acute Myocardial Infarction | 2012 | 6 | 43 | 63% |
| Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: A meta-analysis of prospective studies | 2014 | 1 | 25 | 84% |
| Hyperglycemia and Acute Coronary Syndrome: A Systematic Review of Hyperglycemia's Impact on ACS | 2010 | 7 | 13 | 69% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTENS CARDIAC CORONARY UNIT | 5 | 38% | 0.6% | 10 |
| 2 | HEART VESSEL | 3 | 19% | 0.9% | 14 |
| 3 | KYUSYU CARDIOVASC | 2 | 67% | 0.1% | 2 |
| 4 | SANA HOSP GER HEIM | 2 | 67% | 0.1% | 2 |
| 5 | NORDRHEIN WESTFALEN KLIN | 1 | 100% | 0.1% | 2 |
| 6 | PHYSIOL FUNCT INVEST | 1 | 50% | 0.1% | 2 |
| 7 | LIPID DISORDERS | 1 | 40% | 0.1% | 2 |
| 8 | PEOPLES HOSP ZHENGZHOU | 1 | 33% | 0.1% | 2 |
| 9 | ANAL CHIM CLIN ENDOCRINOL | 1 | 50% | 0.1% | 1 |
| 10 | BARTS LONDON HLTH CARDIOVASC BIOM | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000188688 | ANTIDIABETIC PHARMACOTHERAPY//CHAIR GERIATR SURG//HEART FAILURE INCOR |
| 2 | 0.0000147612 | INTERMITTENT GLUCOSE//POSTPRANDIAL HYPERGLYCEMIA//GLYCEMIC VARIABILITY |
| 3 | 0.0000138301 | INTENSIVE INSULIN THERAPY//STRESS HYPERGLYCEMIA//TIGHT GLYCEMIC CONTROL |
| 4 | 0.0000120114 | MULTIPLE CAUSE//CHRONIC COMPLICATIONS//DATASUS |
| 5 | 0.0000090304 | GLUCOSE INSULIN POTASSIUM//THORAC PHYSIOL//GIK |
| 6 | 0.0000082520 | DIABETIC CARDIOMYOPATHY//DIABETIC HEART//ENVIRONM OCCUPAT AGR HLTH |
| 7 | 0.0000082499 | ACT STUDY//ASPIRIN DOSE//ANTIOXIDANT DEFENSE MECHANISM |
| 8 | 0.0000081023 | IMPAIRED FASTING GLUCOSE//DIABETES PREVENTION//IMPAIRED GLUCOSE TOLERANCE |
| 9 | 0.0000078319 | SYNTAX SCORE//LEFT MAIN//LEFT MAIN CORONARY ARTERY DISEASE |
| 10 | 0.0000071012 | INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30 |